Merck & Co., Inc.
MRK
$115.88
$2.882.55%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.87% | 4.97% | 3.72% | -1.90% | -1.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.87% | 4.97% | 3.72% | -1.90% | -1.56% |
| Cost of Revenue | 14.54% | 15.86% | -3.68% | -7.80% | -1.20% |
| Gross Profit | 2.18% | 1.58% | 5.97% | -0.15% | -1.66% |
| SG&A Expenses | 6.74% | 1.56% | -2.44% | -2.08% | 3.71% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.42% | 46.47% | -16.81% | 1.59% | 2.56% |
| Operating Income | 1.06% | -33.62% | 61.53% | -7.22% | -7.14% |
| Income Before Tax | -159.87% | -17.99% | 64.91% | -16.77% | 4.11% |
| Income Tax Expenses | -13.33% | 7.51% | 3.12% | 4.77% | -9.41% |
| Earnings from Continuing Operations | -183.44% | -20.89% | 83.07% | -18.92% | 6.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 150.00% | 200.00% | 50.00% | 83.33% | -20.00% |
| Net Income | -183.48% | -20.84% | 83.24% | -18.85% | 6.66% |
| EBIT | 1.06% | -33.62% | 61.53% | -7.22% | -7.14% |
| EBITDA | 5.66% | -26.25% | 47.86% | -6.21% | -4.45% |
| EPS Basic | -185.20% | -19.28% | 86.10% | -18.07% | 7.08% |
| Normalized Basic EPS | -0.60% | -34.91% | 56.23% | -6.32% | -6.05% |
| EPS Diluted | -185.57% | -19.28% | 86.98% | -17.76% | 7.49% |
| Normalized Diluted EPS | -0.28% | -34.91% | 56.48% | -6.06% | -5.95% |
| Average Basic Shares Outstanding | -2.02% | -1.93% | -1.54% | -0.95% | -0.39% |
| Average Diluted Shares Outstanding | -2.33% | -1.93% | -1.69% | -1.22% | -0.51% |
| Dividend Per Share | 4.94% | 5.19% | 5.19% | 5.19% | 5.19% |
| Payout Ratio | -2.23% | 0.31% | -0.43% | 0.29% | -0.01% |